Hawthorne-based Taro Pharmaceutical gets tentative approval for generic drug
-
- February
- 26
Taro Pharmaceutical Industries Ltd., which has operations in Hawthorne, said this morning it has received tentative government approval for its Ranitidine syrup, a product that treats ulcers, gastroesophageal reflux disease and other gastro-intestinal problems.
The U.S. Food and Drug Administration has ruled that the product is safe and effective when used properly, the company said.
The company said the approval means it can market the drug when other companies’ patents expire. That is expected to happen in 2009, the company said.
Taro shares closed Friday at $9.10, up 10 cents.
This entry was posted
on Monday, February 26th, 2007 at 10:42 am by Allan Drury.
You can follow any responses to this entry through the RSS 2.0 feed.
Share and Enjoy: 
| 
Print
| 
Email
